HDCEX | VIVAX | HDCEX / VIVAX | |
Total Expense Ratio | 2.57 | 0.17 | 1,512% |
Annual Report Gross Expense Ratio | 2.57 | 0.17 | 1,512% |
Fund Existence | 12 years | 33 years | - |
Gain YTD | 6.122 | 4.573 | 134% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 40.2M | 195B | 0% |
Annual Yield % from dividends | 0.00 | 2.06 | - |
Returns for 1 year | 11.64 | 5.69 | 205% |
Returns for 3 years | 27.58 | 35.05 | 79% |
Returns for 5 years | 31.59 | 71.01 | 44% |
Returns for 10 years | 20.02 | 108.32 | 18% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
PVCT | 0.07 | N/A | +2.81% |
Provectus Biopharmaceuticals, Inc. | |||
AVCVF | 0.07 | N/A | N/A |
Monitor Ventures Inc. | |||
KSANF | 14.65 | N/A | N/A |
Kansai Paint Co., Ltd. | |||
NSANY | 4.23 | -0.05 | -1.17% |
Nissan Motor Co., Ltd. | |||
MNARF | 13.51 | -0.19 | -1.39% |
Morguard North American Residential Real Estate Investment Trust |